The FDA has denied ITM Isotopes Technologies’ lead pipeline candidate for a rare group of tumors due to qualms over the drug’s manufacturing.
ITM neuroendocrine tumor drug spurned by FDA over manufacturing qualms
Latest from Blog
UNC Nutrition Obesity Research Center awarded $5.8M NIH renewal through 2031 – UNC Gillings School of Global Public Health
September 18, 2026 The Center brings together clinicians, public health researchers, basic and behavioral scientists, and others who share a common goal of advancing nutrition and obesity research from infancy through older adulthood. Post Views: 3
Brightcore Nutrition
News Channel 3 – Memphis, TN News, Sports and Weather Post Views: 4
Why your hair, nails, and skin are the first clues of a nutrition gap on Ozempic
A peer reviewed review coauthored by a Beverly Hills surgeon argues the hollowed look from rapid GLP-1 weight loss is partly a nutrition problem, and one you can do something about. Post
Quality nutrition for a quality life
WFLA News Channel 8 On Your Side in Tampa Bay Florida Post Views: 4
‘Fully compliant’: Nestlé India responds to FSSAI action over infant nutrition products
Nestlé India on Friday said its infant nutrition products are fully compliant with applicable regulations, responding to legal action initiated by the Food Safety and Standards Authority of India (FSSAI) over promotional